CIMIP2B and breast cancer: Secondly, the expression of FAM166 B is related to the prognosis of breast cancer, and the expression level of FAM166 B in breast cancer is closely related to macrophages and CD4+T cells, which indicates that the recruitment and regulation of immune infiltrating cells in breast cancer may be mediated by FAM166B (54).